Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carden

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Transfusion|July 15, 2009
A conversation with David Perez, president and CEO of CaridianBCTR Carden
Journal of the American Optometric Association|November 1, 1983
An unusual case of papillary cystadenoma lymphomatosum of the plica semilunarisR Carden
BJA Education|February 2, 2026
Management of aneurysmal subarachnoid haemorrhage in critical careR Carden, A Zoumprouli
The American Journal of Gastroenterology|September 1, 2005
Written in response to Scott LD: treating hepatitis C in active injection drug usersBrian R Edlin, Michael R Carden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2006
Injection drug users: the overlooked core of the hepatitis C epidemicBrian R Edlin, Michael R Carden
Anaesthesia and Intensive Care|April 1, 1994
Suxamethonium-induced prolonged apnoea in a premature neonateG P Frawley, J R Carden
Clinical Leadership & Management Review : the Journal of CLMA|March 10, 2001
Strategic planning in a clinical environmentL P Vetter, R Carden, D S Wilkinson
Current Hepatitis Reports|June 27, 2013
Managing Hepatitis C in Users of Illicit DrugsBrian R Edlin, Michael R Carden, Stephen J Ferrando
Molecular Neurobiology|February 14, 2019
Transferrin Enhances Microglial Phagocytic CapacityTomás R Carden, Jorge Correale, Juana M Pasquini, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 30, 2016
Angiotensin-(1-7) protects from brain damage induced by shiga toxin 2-producing enterohemorrhagic Escherichia coliJorge Goldstein, Tomás R Carden, María J Perez, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Transfusion|July 15, 2009
A conversation with David Perez, president and CEO of CaridianBCTR Carden
Journal of the American Optometric Association|November 1, 1983
An unusual case of papillary cystadenoma lymphomatosum of the plica semilunarisR Carden
BJA Education|February 2, 2026
Management of aneurysmal subarachnoid haemorrhage in critical careR Carden, A Zoumprouli
The American Journal of Gastroenterology|September 1, 2005
Written in response to Scott LD: treating hepatitis C in active injection drug usersBrian R Edlin, Michael R Carden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2006
Injection drug users: the overlooked core of the hepatitis C epidemicBrian R Edlin, Michael R Carden
Anaesthesia and Intensive Care|April 1, 1994
Suxamethonium-induced prolonged apnoea in a premature neonateG P Frawley, J R Carden
Clinical Leadership & Management Review : the Journal of CLMA|March 10, 2001
Strategic planning in a clinical environmentL P Vetter, R Carden, D S Wilkinson
Current Hepatitis Reports|June 27, 2013
Managing Hepatitis C in Users of Illicit DrugsBrian R Edlin, Michael R Carden, Stephen J Ferrando
Molecular Neurobiology|February 14, 2019
Transferrin Enhances Microglial Phagocytic CapacityTomás R Carden, Jorge Correale, Juana M Pasquini, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 30, 2016
Angiotensin-(1-7) protects from brain damage induced by shiga toxin 2-producing enterohemorrhagic Escherichia coliJorge Goldstein, Tomás R Carden, María J Perez, et al.
Pageof 2